Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Modulation of amygdala reactivity following rapidly acting interventions for major depression
Joana Loureiro, Amber M. Leaver, Megha Vasavada, et al.
Human Brain Mapping (2020) Vol. 41, Iss. 7, pp. 1699-1710
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

Ketamine and Serotonergic Psychedelics: Common Mechanisms Underlying the Effects of Rapid-Acting Antidepressants
Bashkim Kadriu, Maximillian Greenwald, Ioline D. Henter, et al.
The International Journal of Neuropsychopharmacology (2020) Vol. 24, Iss. 1, pp. 8-21
Open Access | Times Cited: 81
Enhanced default mode network functional connectivity links with electroconvulsive therapy response in major depressive disorder
Yajing Pang, Qiang Wei, Shanshan Zhao, et al.
Journal of Affective Disorders (2022) Vol. 306, pp. 47-54
Closed Access | Times Cited: 50
Rapid neuroplasticity changes and response to intravenous ketamine: a randomized controlled trial in treatment-resistant depression
Jared M. Kopelman, Timothy A. Keller, Benjamin Panny, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 29
The effect of ketamine on anhedonia: improvements in dimensions of anticipatory, consummatory, and motivation-related reward deficits
Danica Nogo, Ashitija Jasrai, Haeun Kim, et al.
Psychopharmacology (2022) Vol. 239, Iss. 7, pp. 2011-2039
Closed Access | Times Cited: 32
Changes in white matter microstructure following serial ketamine infusions in treatment resistant depression
Brandon Taraku, Roger P. Woods, Michael Boucher, et al.
Human Brain Mapping (2023) Vol. 44, Iss. 6, pp. 2395-2406
Open Access | Times Cited: 16
Post-traumatic stress disorder: the role of the amygdala and potential therapeutic interventions – a review
Lori L. Davis, Mark B. Hamner
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 6
Effects of Serial Ketamine Infusions on Corticolimbic Functional Connectivity in Major Depression
Megha Vasavada, Joana Loureiro, Antoni Kubicki, et al.
Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2020) Vol. 6, Iss. 7, pp. 735-744
Open Access | Times Cited: 42
Depression treatment response to ketamine: sex-specific role of interleukin-8, but not other inflammatory markers
Jennifer L. Kruse, Megha Vasavada, Richard G. Olmstead, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 35
Efficacy and adverse effects of ketamine versus electroconvulsive therapy for major depressive disorder: A systematic review and meta-analysis
Debora de A. Simoes Moreira, Luís Eduardo Gauer, Guilherme Teixeira, et al.
Journal of Affective Disorders (2023) Vol. 330, pp. 227-238
Open Access | Times Cited: 14
Botulinum Toxin Treatment for Depression: A New Paradigm for Psychiatry
Eric Finzi
Toxins (2023) Vol. 15, Iss. 5, pp. 336-336
Open Access | Times Cited: 14
Ketamine treatment for anhedonia in unipolar and bipolar depression: a systematic review
Aleksander Kwaśny, Julia Kwaśna, Alina Wilkowska, et al.
European Neuropsychopharmacology (2024) Vol. 86, pp. 20-34
Closed Access | Times Cited: 5
Neuroimaging correlates and predictors of response to repeated-dose intravenous ketamine in PTSD: preliminary evidence
Agnes Norbury, Sarah Rutter, Abigail B. Collins, et al.
Neuropsychopharmacology (2021) Vol. 46, Iss. 13, pp. 2266-2277
Open Access | Times Cited: 31
Intrinsic Connectivity Networks of Glutamate-Mediated Antidepressant Response: A Neuroimaging Review
Ilya Demchenko, Vanessa K. Tassone, Sidney H. Kennedy, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 21
Brain-based correlates of antidepressant response to ketamine: a comprehensive systematic review of neuroimaging studies
Gustavo C. Medeiros, Malcolm Matheson, Isabella Demo, et al.
The Lancet Psychiatry (2023) Vol. 10, Iss. 10, pp. 790-800
Closed Access | Times Cited: 11
Ketamine versus electroconvulsive therapy for major depressive episode: An updated systematic review and non-inferiority meta-analysis
A. Petrucci, João Vítor Andrade Fernandes, Isabelle Albuquerque Reis, et al.
Psychiatry Research (2024) Vol. 339, pp. 115994-115994
Closed Access | Times Cited: 4
Mapping Electroconvulsive Therapy Induced Neuroplasticity: Towards a Multilevel Understanding of the Available Clinical Literature – A Scoping Review
Maarten Laroy, Louise Emsell, Mathieu Vandenbulcke, et al.
Neuroscience & Biobehavioral Reviews (2025), pp. 106143-106143
Closed Access
Is ketamine an appropriate alternative to ECT for patients with treatment resistant depression? A systematic review
Jolien K. E. Veraart, Sanne Y. Smith-Apeldoorn, Harm‐Pieter Spaans, et al.
Journal of Affective Disorders (2020) Vol. 281, pp. 82-89
Open Access | Times Cited: 30
Functional connectivity between the amygdala and subgenual cingulate gyrus predicts the antidepressant effects of ketamine in patients with treatment‐resistant depression
Tomoyuki Nakamura, Masaru Tomita, Naoki Horikawa, et al.
Neuropsychopharmacology Reports (2021) Vol. 41, Iss. 2, pp. 168-178
Open Access | Times Cited: 23
Neuroimaging-Derived Biomarkers of the Antidepressant Effects of Ketamine
Artemis Zavaliangos‐Petropulu, Noor Al‐Sharif, Brandon Taraku, et al.
Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2022) Vol. 8, Iss. 4, pp. 361-386
Open Access | Times Cited: 18
Deep brain stimulation normalizes amygdala responsivity in treatment-resistant depression
Nora Runia, Isidoor O. Bergfeld, Bart P. de Kwaasteniet, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 6, pp. 2500-2507
Open Access | Times Cited: 10
Review: The use of functional magnetic resonance imaging (fMRI) in clinical trials and experimental research studies for depression
Vasileia Kotoula, Jennifer W. Evans, Claire Punturieri, et al.
Frontiers in Neuroimaging (2023) Vol. 2
Open Access | Times Cited: 10
Changed brain entropy and functional connectivity patterns induced by electroconvulsive therapy in majoy depression disorder
Siyu Fan, Jiahua Zhang, Yue Wu, et al.
Psychiatry Research Neuroimaging (2024), pp. 111788-111788
Closed Access | Times Cited: 3
Chemogenetic targeting TRPV1 in obesity-induced depression: Unveiling therapeutic potential of eicosapentaenoic acid and acupuncture
Yi‐Wen Lin, Szu‐Wei Cheng, Wen‐Chun Liu, et al.
Brain Behavior and Immunity (2024) Vol. 123, pp. 771-783
Closed Access | Times Cited: 3
Functional MRI markers for treatment-resistant depression: Insights and challenges
Vasileia Kotoula, Jennifer W. Evans, Claire Punturieri, et al.
Progress in brain research (2023), pp. 117-148
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top